为疫苗决策提供信息:疫苗战略多属性排序工具——SMART Vaccines 2.0
SMART Vaccines 2.0 是一款正在开发的基于网络的软件工具,旨在支持多方利益相关者在疫苗研发与部署投资优先排序中的决策。该工具改编自美国医学研究所委员会的工作,基于人群、疾病、经济及疫苗特异性数据,结合用户所选属性的个体偏好与权重,生成疫苗研发或接种优先级的加权推荐。美国卫生与公众服务部国家疫苗规划办公室与美国国立卫生研究院福格蒂国际中心正在推进其设计与效用开发,并计划通过利益相关者参与和试点项目明确属性偏好及相关数据与模型需求。
要点
- SMART Vaccines 2.0 为基于网络的疫苗投资优先级排序工具,改编自美国医学研究所委员会的工作。
- 工具基于人群、疾病、经济及疫苗特异性数据,结合用户所选属性的偏好与权重生成加权推荐。
- 美国卫生与公众服务部国家疫苗规划办公室与美国国立卫生研究院福格蒂国际中心正在推进其开发。
核心结论
- SMART Vaccines 2.0 框架的当前开发工作旨在基于人群、疾病、经济及疫苗特异性数据,结合用户所选属性的个体偏好与权重,生成疫苗研发或接种优先级的加权推荐。
- 该工具旨在突出数据需求并创造透明度,以促进决策者之间的对话与信息共享,并优化资源投资以改善健康结果。
- 作者旨在通过相关利益相关者社区的参与展示 SMART Vaccines 2.0 的效用,并确定少量试点项目以明确界定属性偏好及相关的数据与模型需求。
研究设计与样本
- SMART Vaccines 2.0 是一款正在开发的基于网络的工具,改编自美国医学研究所委员会的工作(IOM,2015)。
- 其设计与效用开发由美国卫生与公众服务部国家疫苗规划办公室与美国国立卫生研究院福格蒂国际中心推进。
- 开发工作旨在通过利益相关者参与和试点项目明确属性偏好及相关的数据与模型需求。
主要发现
- 不断增长的证据涉及新兴疫苗技术、疾病负担趋势、疫苗开发与部署相关成本以及通过接种疫苗预防疾病所获得的收益等一系列其他因素,可为新疫苗和改进疫苗的投资决策及现有疫苗的针对性利用提供信息。
- 认识到一系列输入因素影响这些决策,SMART Vaccines 2.0 正在开发为基于网络的工具,以突出数据需求并创造透明度,促进决策者之间的对话与信息共享。
- 该框架结合健康、经济、人口学、公众关注、科学与商业、规划及政治考量等用户所选属性的估值与权重,生成加权推荐。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
SMART Vaccines 2.0 software is being developed to support decision-making among multiple stakeholders in the process of prioritizing investments to optimize the outcomes of vaccine development and deployment. Vaccines and associated vaccination programs are one of the most successful and effective public health interventions to prevent communicable diseases and vaccine researchers are continually working towards expanding targets for communicable and non-communicable diseases through preventive and therapeutic modes. A growing body of evidence on emerging vaccine technologies, trends in disease burden, costs associated with vaccine development and deployment, and benefits derived from disease prevention through vaccination and a range of other factors can inform decision-making and investment in new and improved vaccines and targeted utilization of already existing vaccines. Recognizing that an array of inputs influences these decisions, the strategic multi-attribute ranking method for vaccines (SMART Vaccines 2.0) is in development as a web-based tool-modified from a U.S. Institute of Medicine Committee effort (IOM, 2015)-to highlight data needs and create transparency to facilitate dialogue and information-sharing among decision-makers and to optimize the investment of resources leading to improved health outcomes. Current development efforts of the SMART Vaccines 2.0 framework seek to generate a weighted recommendation on vaccine development or vaccination priorities based on population, disease, economic, and vaccine-specific data in combination with individual preference and weights of user-selected attributes incorporating valuations of health, economics, demographics, public concern, scientific and business, programmatic, and political considerations. Further development of the design and utility of the tool is being carried out by the National Vaccine Program Office of the Department of Health and Human Services and the Fogarty International Center of the National Institutes of Health. We aim to demonstrate the utility of SMART Vaccines 2.0 through the engagement of a community of relevant stakeholders and to identify a limited number of pilot projects to determine explicitly defined attribute preferences and the related data and model requirements that are responsive to user needs and able to improve the use of evidence for vaccine-related decision-making and consequential priorities of vaccination options.
引用
- Knobler S, Bok K, Gellin B, et al. Informing vaccine decision-making: A strategic multi-attribute ranking tool for vaccines-SMART Vaccines 2.0. Vaccine. 2016. PMID: 28017435. doi:10.1016/j.vaccine.2016.10.086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。